Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease
Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the benefit of treatment with a physician administered intracanalicular
dexamethasone insert in patients with dry eye who are beginning treatment with Xiidra
(lifitegrast ophthalmic solution) to reduce the signs and symptoms of dry eye disease.